Skip to main content
. 2023 Jan 20;56:101816. doi: 10.1016/j.eclinm.2022.101816

Fig. 3.

Fig. 3

Kaplan–Meier analysis of progression-free survival (PFS). Data in the entire cohort (3A) and in the propensity score-matched cohort (3B) in patients with intermediate-stage recurrent hepatocellular carcinoma (RHCC).